COVID-19

News

Tokyo, Japan at the control tower of Haneda Airport.

Tokyo airport trials CommonPass digital health passport

All Nippon Airways (ANA) has begun a trial of its CommonPass app showing a traveller’s COVID-19 status at Tokyo’s Haneda Airport.

News

Lilly and GSK/Vir antibody pairing offers resistant COVID-19...

Two antibodies targeting different parts of the COVID-19 virus spike protein, from Eli Lilly and GlaxoSmithKline/Vir Biotech, can cut viral load dramatically within a week.

News

World leaders call for international pandemic preparedness t...

More than 20 world leaders have called for an international treaty for pandemic preparedness to protect the world from future health crises.

News

scientifically visualization of a coronavirus spike protein

CHMP backs Celltrion's regdanvimab antibody for COVID-19

The EU looks set to approve emergency use of a third antibody therapy for COVID-19 after its human medicines committee backed use of Celltrion's regdanvimab at its March meeting. <

News

Regeneron's antibody cocktail cuts COVID hospitalisation in ...

Regeneron has posted findings from a large trial of its COVID-19 antibody cocktail showing the therapy reduced risk of hospitalisation or death by 70%.

News

AI drug discovery player 1910 Genetics debuts with $26m war ...

There's a new kid on the block among companies using artificial intelligence in drug discovery, after 1910 Genetics launched today with $26 million in financing.

Tokyo airport trials CommonPass digital health passport

Lilly and GSK/Vir antibody pairing offers resistant COVID-19...

World leaders call for international pandemic preparedness t...

CHMP backs Celltrion's regdanvimab antibody for COVID-19

Regeneron's antibody cocktail cuts COVID hospitalisation in ...

AI drug discovery player 1910 Genetics debuts with $26m war ...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks